Document Detail


Intensive Insulin Therapy Increases the Risk of Hypoglycemia in Neurocritical Care Patients.
MedLine Citation:
PMID:  21593693     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Intensive insulin therapy protocols are widely used in intensive care medicine. A disadvantage of these protocols may be the occurrence of hypoglycemic episodes. Neurocritical care patients are particularly vulnerable to the effects of hypoglycemia. We aimed to study the risk of hypoglycemia in neurocritical care patients in relation to intensive insulin therapy. METHODS: To determine the effects of 2 different intensive insulin therapy protocols on glucose levels and hypoglycemia incidence, we collected data before and after implementation of the protocols in 2 university hospitals. The risk of hypoglycemia (blood glucose level below 3.0 mmol/L) was studied retrospectively with logistic regression analyses. RESULTS: In hospital A, data were obtained on 152 patients before implementation of the protocol and on 649 patients after implementation of the protocol. In hospital B, data were obtained on 111 patients before implementation of the protocol and on 118 patients thereafter. Implementation of intensive insulin therapy protocols increased the time spent in the desired blood glucose range of 4.6 to 6.0 mmol/L in both hospitals, but increased the risk of hypoglycemia: the absolute risk of hypoglycemia during intensive care unit admission increased in hospital A from 14.5% to 20.3% (adjusted odds ratio=1.3; 95% confidence interval: 0.8-2.3) and in hospital B from 3.6% to 29.7% (adjusted odds ratio=28.6; 95% confidence interval: 5.9-138.9). CONCLUSIONS: Implementation of intensive insulin therapy protocols in neurocritical care patients not only seems to increase the time spent in the desired blood glucose range, but also seems to increase the risk of hypoglycemia. The risk of hypoglycemia strongly depends on characteristics of the intensive insulin therapy protocol.
Authors:
Charlotte A M Tiemessen; Cornelia W E Hoedemaekers; Freya M van Iersel; Gerrit H J Rösken; Johannes van der Hoeven; Geert-Jan Biessels; Arjen J C Slooter
Related Documents :
3698483 - Influence of glucose on collagen and protein production in cultured human skin fibrobla...
3732633 - Glycation of skin collagen in type i diabetes mellitus. correlation with long-term comp...
8216403 - A quantitative assessment of limited joint mobility in patients with diabetes. goniomet...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-17
Journal Detail:
Title:  Journal of neurosurgical anesthesiology     Volume:  -     ISSN:  1537-1921     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8910749     Medline TA:  J Neurosurg Anesthesiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departments of *Intensive Care Medicine ‡Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht †Department of Intensive Care, St Radboud University Medical Center, Nijmegen, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cell-Free DNA-A Marker to Predict Ischemic Brain Damage in a Rat Stroke Experimental Model.
Next Document:  PRO: the "Lund concept" for treatment of patients with severe traumatic brain injury.